View in EDS HTML Full Text PDF Full Text

Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.

Saved in:
Bibliographic Details
Title: Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.
Authors: Cabezas-Camarero S; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Calle Profesor Martin Lagos S/N, 28040, Madrid, Spain., Pérez-Alfayate R; Department of Neurosurgery, Instituto de Neurociencias, Hospital Clínico Universitario San Carlos, Madrid, Spain., García-Barberán V; Molecular Oncology Laboratory, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Polidura MC; Radiology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Gómez-Ruiz MN; Radiology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Casado-Fariñas I; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Subhi-Issa IA; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Hernández JCP; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Garre P; Molecular Diagnosis Unit, Clinical Chemistry Department, IML, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clinico Universitario San Carlos, Madrid, Spain., Díaz-Millán I; Research Nurse, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain., Pérez-Segura P; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Jun 08; Vol. 14, pp. 17588359221100863. Date of Electronic Publication: 2022 Jun 08 (Print Publication: 2022).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35694191
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cabezas-Camarero+S%22">Cabezas-Camarero S</searchLink>; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Calle Profesor Martin Lagos S/N, 28040, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Alfayate+R%22">Pérez-Alfayate R</searchLink>; Department of Neurosurgery, Instituto de Neurociencias, Hospital Clínico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Barberán+V%22">García-Barberán V</searchLink>; Molecular Oncology Laboratory, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Polidura+MC%22">Polidura MC</searchLink>; Radiology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez-Ruiz+MN%22">Gómez-Ruiz MN</searchLink>; Radiology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Casado-Fariñas+I%22">Casado-Fariñas I</searchLink>; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Subhi-Issa+IA%22">Subhi-Issa IA</searchLink>; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández+JCP%22">Hernández JCP</searchLink>; Pathology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Garre+P%22">Garre P</searchLink>; Molecular Diagnosis Unit, Clinical Chemistry Department, IML, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clinico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Díaz-Millán+I%22">Díaz-Millán I</searchLink>; Research Nurse, Medical Oncology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Segura+P%22">Pérez-Segura P</searchLink>; Medical Oncology Department, Hospital Clínico Universitario San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2022 Jun 08; Vol. 14, pp. 17588359221100863. <i>Date of Electronic Publication: </i>2022 Jun 08 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35694191
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17588359221100863
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17588359221100863
    Titles:
      – TitleFull: Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cabezas-Camarero S
      – PersonEntity:
          Name:
            NameFull: Pérez-Alfayate R
      – PersonEntity:
          Name:
            NameFull: García-Barberán V
      – PersonEntity:
          Name:
            NameFull: Polidura MC
      – PersonEntity:
          Name:
            NameFull: Gómez-Ruiz MN
      – PersonEntity:
          Name:
            NameFull: Casado-Fariñas I
      – PersonEntity:
          Name:
            NameFull: Subhi-Issa IA
      – PersonEntity:
          Name:
            NameFull: Hernández JCP
      – PersonEntity:
          Name:
            NameFull: Garre P
      – PersonEntity:
          Name:
            NameFull: Díaz-Millán I
      – PersonEntity:
          Name:
            NameFull: Pérez-Segura P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 06
              Text: 2022 Jun 08
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1